LOTEMAX

Lotemax Adverse Events Reported to the FDA Over Time

How are Lotemax adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lotemax, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lotemax is flagged as the suspect drug causing the adverse event.

Most Common Lotemax Adverse Events Reported to the FDA

What are the most common Lotemax adverse events reported to the FDA?

Eye Irritation	43 (4.26%)
Ocular Hyperaemia	26 (2.57%)
Visual Acuity Reduced	26 (2.57%)
Eye Pain	25 (2.48%)
Condition Aggravated	24 (2.38%)
Vision Blurred	24 (2.38%)
Drug Ineffective	22 (2.18%)
Headache	19 (1.88%)
Intraocular Pressure Increased	18 (1.78%)
Insomnia	17 (1.68%)
Drug Hypersensitivity	15 (1.49%)
	Show More
Eye Swelling	15 (1.49%)
Anxiety	14 (1.39%)
Corneal Epithelium Defect	13 (1.29%)
Corneal Scar	13 (1.29%)
Dizziness	13 (1.29%)
Eye Pruritus	13 (1.29%)
Lacrimation Increased	13 (1.29%)
Depression	12 (1.19%)
Eyelid Oedema	12 (1.19%)
Keratoconjunctivitis Sicca	12 (1.19%)
Hypersensitivity	11 (1.09%)
Dyspnoea	10 (.99%)
Eye Discharge	10 (.99%)
Foreign Body Sensation In Eyes	10 (.99%)
Endophthalmitis	9 (.89%)
Giant Papillary Conjunctivitis	9 (.89%)
Keratitis	9 (.89%)
Rhinorrhoea	9 (.89%)
Chemical Burns Of Eye	8 (.79%)
Contact Lens Intolerance	8 (.79%)
Impaired Driving Ability	8 (.79%)
Impaired Work Ability	8 (.79%)
Nausea	8 (.79%)
Photophobia	8 (.79%)
Toothache	8 (.79%)
Abnormal Sensation In Eye	7 (.69%)
Cataract	7 (.69%)
Mydriasis	7 (.69%)
Visual Impairment	7 (.69%)
Corneal Oedema	6 (.59%)
Delusion	6 (.59%)
Dermatitis Exfoliative	6 (.59%)
Drug Ineffective For Unapproved Ind...	6 (.59%)
Drug Interaction	6 (.59%)
Dry Eye	6 (.59%)
Eye Inflammation	6 (.59%)
Hypertension	6 (.59%)
Incorrect Drug Administration Durat...	6 (.59%)
Lip Dry	6 (.59%)
Nasal Congestion	6 (.59%)
Ocular Toxicity	6 (.59%)
Paranoia	6 (.59%)
Sinus Headache	6 (.59%)
Suicidal Ideation	6 (.59%)
Suicide Attempt	6 (.59%)
Weight Decreased	6 (.59%)
Blood Glucose Increased	5 (.5%)
Corneal Abrasion	5 (.5%)
Dysgeusia	5 (.5%)
Eyelids Pruritus	5 (.5%)
Madarosis	5 (.5%)
Oropharyngeal Pain	5 (.5%)
Ulcerative Keratitis	5 (.5%)
Vertigo	5 (.5%)
Agitation	4 (.4%)
Burning Sensation	4 (.4%)
Conjunctivitis Allergic	4 (.4%)
Corneal Infection	4 (.4%)
Erythema	4 (.4%)
Facial Pain	4 (.4%)
Formication	4 (.4%)
Impaired Healing	4 (.4%)
Incorrect Route Of Drug Administrat...	4 (.4%)
Medication Residue	4 (.4%)
Mutism	4 (.4%)
Off Label Use	4 (.4%)
Pain	4 (.4%)
Photosensitivity Reaction	4 (.4%)
Restlessness	4 (.4%)
Stress	4 (.4%)
Swelling Face	4 (.4%)
Throat Irritation	4 (.4%)
Alopecia	3 (.3%)
Atrophy Of Globe	3 (.3%)
Corneal Disorder	3 (.3%)
Corneal Perforation	3 (.3%)
Corneal Pigmentation	3 (.3%)
Diarrhoea	3 (.3%)
Feeling Jittery	3 (.3%)
Head Discomfort	3 (.3%)
Keratitis Herpetic	3 (.3%)
Migraine	3 (.3%)
Ocular Discomfort	3 (.3%)
Pain In Extremity	3 (.3%)
Pruritus Generalised	3 (.3%)
Rash	3 (.3%)
Sneezing	3 (.3%)
Urticaria	3 (.3%)
Vomiting	3 (.3%)
Abnormal Dreams	2 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Lotemax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lotemax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lotemax

What are the most common Lotemax adverse events reported to the FDA?

Ocular Infections, Irritations And ...	156 (15.45%)
Eye	84 (8.32%)
Vision	62 (6.14%)
Therapeutic And Nontherapeutic Effe...	41 (4.06%)
Respiratory	39 (3.86%)
Neurological	38 (3.76%)
Ocular Sensory Symptoms	35 (3.47%)
Epidermal And Dermal Conditions	33 (3.27%)
Anterior Eye Structural Change, Dep...	32 (3.17%)
Allergic Conditions	30 (2.97%)
Headaches	28 (2.77%)
	Show More
Injuries	28 (2.77%)
Anxiety Disorders	24 (2.38%)
Sleep Disorders	19 (1.88%)
Infections - Pathogen Unspecified	18 (1.78%)
Neurological, Special Senses And Ps...	18 (1.78%)
Lifestyle Issues	16 (1.58%)
Gastrointestinal Signs	15 (1.49%)
Medication Errors	14 (1.39%)
Chemical Injury And Poisoning	13 (1.29%)
Upper Respiratory Tract Disorders	13 (1.29%)
Depressed Mood Disorders	12 (1.19%)
Suicidal And Self-injurious Behavio...	12 (1.19%)
Dental And Gingival Conditions	10 (.99%)
Ocular Neuromuscular	10 (.99%)
Disturbances In Thinking	9 (.89%)
Skin Appendage Conditions	9 (.89%)
Inner Ear And Viiith Cranial Nerve	7 (.69%)
Product Quality Issues	7 (.69%)
Salivary Gland Conditions	7 (.69%)
Viral Infectious	7 (.69%)
Metabolic, Nutritional And Blood Ga...	6 (.59%)
Ocular Injuries	6 (.59%)
Oral Soft Tissue Conditions	6 (.59%)
Personality Disorders	6 (.59%)
Physical Examination Topics	6 (.59%)
Vascular Hypertensive	6 (.59%)
Musculoskeletal And Connective Tiss...	5 (.5%)
Changes In Physical Activity	4 (.4%)
Communication Disorders	4 (.4%)
Cranial Nerve Disorders	4 (.4%)
Therapeutic Procedures And Supporti...	4 (.4%)
Tissue	4 (.4%)
Angiedema And Urticaria	3 (.3%)
Aural	3 (.3%)
Bacterial Infectious	3 (.3%)
Gastrointestinal Motility And Defec...	3 (.3%)
Glaucoma And Ocular Hypertension	3 (.3%)
Ocular Structural Change, Deposit A...	3 (.3%)
Administration Site Reactions	2 (.2%)
Hearing	2 (.2%)
Immunodeficiency Syndromes	2 (.2%)
Joint	2 (.2%)
Manic And Bipolar Mood Disorders	2 (.2%)
Mental Impairment	2 (.2%)
Movement Disorders	2 (.2%)
Neurological Disorders Of The Eye	2 (.2%)
Procedural And Device Related Injur...	2 (.2%)
Schizophrenia And Other Psychotic	2 (.2%)
Synovial And Bursal	2 (.2%)
Tongue Conditions	2 (.2%)
Urinary Tract Signs	2 (.2%)
Vascular	2 (.2%)
Appetite And General Nutritional	1 (.1%)
Cardiac And Vascular Investigations	1 (.1%)
Cardiac Disorder Signs	1 (.1%)
Eye Disorders Congenital	1 (.1%)
Fungal Infectious	1 (.1%)
Glucose Metabolism Disorders	1 (.1%)
Immune	1 (.1%)
Immunology And Allergy	1 (.1%)
Lipid Analyses	1 (.1%)
Mood Disorders	1 (.1%)
Ocular Hemorrhages And Vascular	1 (.1%)
Psychiatric And Behavioural Symptom...	1 (.1%)
Retina, Choroid And Vitreous Hemorr...	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lotemax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lotemax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.